Pmgc Holdings Inc. (ELAB) Stock Price & Analysis
Pmgc Holdings Inc. (ELAB) fell 5.15% to USD 0.9 as of July 25, 2026 at 12:31 UTC, according to Nexqual real-time market data.
ELAB last closed at USD 0.95; the session ranged USD 0.87–0.95 on volume of 354,490 shares. Market capitalization is $4.09M, with a 52-week range of USD 0.87–309.89 (NCM). Source: Nexqual, July 25, 2026 at 12:31 UTC.
Key Statistics (as of July 25, 2026 at 12:31 UTC)
| Price | USD 0.9 |
|---|---|
| Change | ▼ 5.15% (down) |
| Previous Close | USD 0.95 |
| Open | USD 0.94 |
| Day Range | USD 0.87 – 0.95 |
| 52-Week Range | USD 0.87 – 309.89 |
| Volume | 354,490 shares |
| Market Cap | $4.09M |
| Exchange | NCM |
Technical Analysis (ELAB)
Nexqual's technical model rates ELAB "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 12:31 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 28.26 (oversold) |
| vs SMA50 | Below (USD 1.42) |
| MACD | -0.15 (negative) |
Analyst Ratings (ELAB)
Wall Street analysts rate ELAB "None", per Nexqual as of July 25, 2026 at 12:31 UTC.
| Consensus Rating | None |
|---|
Earnings (ELAB)
Source: Nexqual, July 25, 2026 at 12:31 UTC.
Financials & Fundamentals (ELAB)
| Total Revenue | $1.27M |
|---|---|
| Gross Margin | -63.15% |
| Operating Margin | -484.68% |
| Profit Margin | +0.00% |
| ROE | -107.90% |
| Debt / Equity | 63.12 |
| Current Ratio | 1.45 |
| Total Cash | $15.21M |
| Total Debt | $7.96M |
| Free Cash Flow | $-2.40M |
Source: Nexqual, July 25, 2026 at 12:31 UTC.
Financial Health Score (ELAB)
Nexqual rates Pmgc Holdings Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 12:31 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Solid — $15M cash vs $8M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Critical — ROE -108%, ROA -33.3% |
Ownership (ELAB)
| Insider Ownership | +9.99% |
|---|---|
| Institutional Ownership | +1.92% |
| Shares Outstanding | 4.54M |
| Float | 4.09M |
| Short % of Float | +17.81% |
Source: Nexqual, July 25, 2026 at 12:31 UTC.
Leadership (ELAB)
Pmgc Holdings Inc. is led by Graydon Bensler C.F.A. (age 33), CEO, CFO, Secretary & Director, per Nexqual as of July 25, 2026 at 12:31 UTC.
| CEO, CFO, Secretary & Director | Graydon Bensler C.F.A. (age 33) |
|---|
Major Backers & Investors (ELAB)
Notable institutional backers of Pmgc Holdings Inc. include Jane Street Group, LLC, Schonfeld Strategic Advisors Llc, Morgan Stanley, according to Nexqual as of July 25, 2026 at 12:31 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Jane Street Group, LLC | 0.7% |
| Schonfeld Strategic Advisors Llc | 0.33% |
| Morgan Stanley | 0.33% |
| Fidelity | 0.15% |
Source: Nexqual, July 25, 2026 at 12:31 UTC.
From Pmgc Holdings Inc.'s Latest SEC 10-K Filing (filed 2026-03-30)
Key Strengths & Strategy (as disclosed to the SEC)
- We believe that the FDA will regulate part of our product candidates as a biologic drug (i.e., a biologic) through the Biologics License Application ("BLA") process under the jurisdiction of the Office of Therapeutic Products within the Center for Biologics Evaluation and Research ("CBER").
- Key operational and technical features include:             6   Competition   The precision machining and specialty metals CNC market is competitive and includes both small niche shops and larger, vertically integrated manufacturers.
- We compete with both domestic and international packaging providers, some of which have substantially greater resources than we do.   AGA Precision Systems — Precision Manufacturing   The precision machining and specialty metals CNC market is competitive and includes both small niche machine shops and larger, vertically integrated manufacturers.
- Our key competitive advantages include:           Sales and Marketing   As a diversified holding company, our sales and marketing activities are conducted both at the parent level and through our wholly owned subsidiaries, with strategies tailored to the specific industries in which each subsidiary operates.
Partnerships
- The Company aspires to either complete an IND submission in 2026, assuming it has sufficient working capital, or to enter into a collaboration with another company to do so.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATPC | Agape ATP Corporation | USD 2.46 | ▼ 2.77% |
| NIVF | NewGenIvf Group Limited | USD 1.1 | ▼ 13.39% |
| BDRX | Biodexa Pharmaceuticals plc | USD 1.65 | ▼ 3.51% |
| JTAI | Jet.AI Inc. | USD 2.04 | ▼ 15.7% |
| NEXR | Nexera Technologies Ltd | USD 0.33 | ▼ 10.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 12:31 UTC. This page is informational and not investment advice.